selected scholarly activity
-
academic article
- School Closure Decisions in Alberta and Ontario during COVID-19: Discourse and Data. Canadian Journal of Political Science. 55:740-746. 2022
- (Re)defining legitimacy in Canadian drug assessment policy? Comparing ideas over time. Health Economics, Policy and Law. 16:424-439. 2021
- “Getting to the Table”: Changing Ideas about Public and Patient Involvement in Canadian Drug Assessment. Journal of Health Politics, Policy and Law. 44:631-663. 2019
- Pharmaceutical policy reform in Canada: lessons from history. Health Economics, Policy and Law. 13:299-322. 2018
- Universal prescription drug coverage in Canada. Healthcare Management Forum. 29:247-254. 2016
- Evaluating the Cost-effectiveness of Pharmaceuticals in Canada. Observatoire des Réformes de Santé. 4. 2016
- Policy Paradigms, Transnationalism, and Domestic Politics, Grace Skogstad, ed., Toronto: University of Toronto Press, 2011, pp. 288.. Canadian Journal of Political Science. 48:727-728. 2015
- Ideas and the Limits on Program Expansion: The Failure of Nationwide Pharmacare in Canada Since 1944. Canadian Journal of Political Science. 46:419-453. 2013
- How the Pace of Change Affects the Scope of Reform: Pharmaceutical Insurance in Canada, Australia, and the United Kingdom. Journal of Health Politics, Policy and Law. 37:779-814. 2012
- Prescription drug subsidies in Australia and New Zealand. Australian Prescriber. 33:2-4. 2010
- The Influence of Institutions on Issue Definition: Children's Environmental Health Policy in the United States and Canada. Journal of Comparative Policy Analysis: Research and Practice. 11:287-307. 2009
-
book
-
chapter
-
conference paper
- PHP25 TOWARD HIGH PERFORMANCE ‘PHARMACARE’ SYSTEMS: A REVIEW OF EXPERIENCES IN SEVEN COUNTRIES. Value in Health. A36-A36. 2008